Dermatitis herpetiformis is a pruritic, blistering skin disease affecting the extensor surface of the limbs, the buttocks and lower back. The autoantigen involved is transglutaminase-3, an enzyme of epidermis. 1 The diagnosis is confirmed by direct immunofluorescence of perilesional skin, with a pathognomonic pattern of granular IgA deposits in papillary dermis, with a false-negative rate of 5%.
gluten intolerance spectrum, share immunomediation by IgA autoantibodies. About 75% of dermatitis herpetiformis patients show villous atrophy, identical to that observed in coeliac disease. 2 Further supporting evidence includes, namely, the resolution of skin lesions after starting gluten-free diet, even if small bowel mucosa is normal; the detection of circulating transglutaminase-3 antibodies in both patient populations; and the finding of subclinical inflammation of small bowel mucosa in dermatitis herpetiformis patients, convincingly link the two conditions. We can therefore state that dermatitis herpetiformis is not just an associated condition, like some autoimmune diseases, but is in fact the cutaneous manifestation of coeliac disease. 3 A 17-year-old adolescent, with no past medical history, presented to our department with itchy papulovesicles and excoriations on the elbows, knees and buttocks, occurring for the past Virtually all patients with coeliac disease or dermatitis herpetiformis have one of these two haplotypes. Its importance derives from the fact that negative results could exclude the diagnosis.
Gluten avoidance is essential for the healing of intestinal mucosa and symptom relief in coeliac disease patients. While the gastrointestinal symptoms take a few weeks to disappear, the itchy skin lesions in dermatitis herpetiformis could take months or years to regress. Consequently, most patients are also treated with dap-sone, which is useful in relieving dermatological symptoms but has no effect on gastrointestinal inflammation. 
